Breast Cancer, Oncologic Disorders, Pelvic Neoplasm, Quality of Life, Radiotherapy; Complications, Satisfaction, Thoracic Neoplasm
Conditions
Keywords
mobile application, radiotherapy, patient-care, mhealth, follow-up, patient satisfaction, quality of life
Brief summary
The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.
Interventions
OTHERmobile application
Oncologic therapy support by means of a mobile application
Sponsors
Heidelberg University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE
Intervention model description
Single-center prospective exploratory study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target * Karnofsky performance score (KPS) ≥ 70%, * Ability to initiate the therapy as an outpatient * ≥ 18 years of age
Exclusion criteria
* Inability to give informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility judged by number of questions answered by each patient on each treatment day | 12-14 weeks | Feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatment-related patient satisfaction | 12-14 weeks | Treatment-related patient satisfaction will be assessed after therapy completion by means of the adapted PSQ-18 questionnaire. |
| Diagnosis-related Quality of Life | 12-14 weeks | Quality of Life will be assessed at before the start and after the completion of radiotherapy, as well as at first follow-up by means of the EORTC QLQ-C30 questionnaire and the respective diagnosis-related questionnaire modules. |
Countries
Germany
Contacts
Primary ContactNils Nicolay, PD Dr. Dr.
Backup ContactRami A. El Shafie
Outcome results
None listed